POZZARI, MARTA
POZZARI, MARTA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.005 secondi).
Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis
2019-01-01 Rebelatto, T. F.; Falavigna, M.; Pozzari, M.; Spada, F.; Cella, C. A.; Laffi, A.; Pellicori, S.; Fazio, N.
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis
2018-01-01 Pozzari, M; Maisonneuve, P; Spada, F; Berruti, A; Amoroso, V; Cella, CHIARA ALESSANDRA; Laffi, A; Pellicori, S; Bertani, E; Fazio, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Should platinum-based chemotherapy be preferred for germline BReast CAncer genes (BRCA) 1 and 2-mutated pancreatic ductal adenocarcinoma (PDAC) patients? A systematic review and meta-analysis | 1-gen-2019 | Rebelatto, T. F.; Falavigna, M.; Pozzari, M.; Spada, F.; Cella, C. A.; Laffi, A.; Pellicori, S.; Fazio, N. | |
| Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis | 1-gen-2018 | Pozzari, M; Maisonneuve, P; Spada, F; Berruti, A; Amoroso, V; Cella, CHIARA ALESSANDRA; Laffi, A; Pellicori, S; Bertani, E; Fazio, N. |